Skip to main content
Erschienen in: Pediatric Cardiology 1/2019

10.09.2018 | Original Article

Drug-Induced Loss of Preexcitation in Pediatric Patients with WPW Pattern During Electrophysiologic Study

verfasst von: C. Paech, F. Wagner, V. Strehlow, R. A. Gebauer

Erschienen in: Pediatric Cardiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Ablation of accessory pathways (AP) is one of the most often performed procedures in pediatric electrophysiology. In pediatric patients these procedures are mostly performed in anaesthesia or sedation. In some of these patients who are referred for electrophysiologic (EP) study, we could observe disappearance of the preexcitation, i.e. antegrade conduction of an AP during introduction of sedation. As a suppression of AP conduction capacities has been reported as negative side effect of propofol and other anaesthetics, the aim of this study was to evaluate risk factors for drug-induced suppression of AP conduction properties. Consecutive, pediatric patients with Wolff–Parkinson–White (WPW) pattern referred for EP study in the period of 2016–2017 were reviewed in retrospect. Patients with complex congenital heart disease were excluded. An entire chart review including ECG, bicycle stress testing, and periprocedural data was performed. In 4 of 37 patients included into the study, loss of preexcitation could be observed during sedation. Data analysis showed weaker conduction capacities of the AP as a risk factor (p = 0.009). Interestingly, absolute (p = 0.11) or adjusted to body weight (p = 0.92) drug doses were not a relevant risk factor. Patients with WPW and weaker conduction capacities of the AP, as implied by an early disappearance of preexcitation during exercise stress testing, seem to be more prone to drug-induced suppression of an AP.
Literatur
1.
Zurück zum Zitat Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE, Pediatric and Congenital Electrophysiology Society (PACES), Heart Rhythm Society (HRS), American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Academy of Pediatrics (AAP), Canadian Heart Rhythm Society (CHRS) (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9(6):1006–1024CrossRefPubMed Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE, Pediatric and Congenital Electrophysiology Society (PACES), Heart Rhythm Society (HRS), American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Academy of Pediatrics (AAP), Canadian Heart Rhythm Society (CHRS) (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9(6):1006–1024CrossRefPubMed
2.
Zurück zum Zitat Pérez ER, Bartolomé FB, Carretero PS, Fernández CS, Mateos EJ, Tarlovsky LG (2008) Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome. Rev Esp Anestesiol Reanim 55(1):26–31CrossRefPubMed Pérez ER, Bartolomé FB, Carretero PS, Fernández CS, Mateos EJ, Tarlovsky LG (2008) Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome. Rev Esp Anestesiol Reanim 55(1):26–31CrossRefPubMed
3.
Zurück zum Zitat Gupta A, Sharma J, Banerjee N, Sood R (2013) Anesthetic management in a patient with Wolff-Parkinson-White syndrome for laparoscopic cholecystectomy. Anesth Essays Res 7(2):270–272CrossRefPubMedPubMedCentral Gupta A, Sharma J, Banerjee N, Sood R (2013) Anesthetic management in a patient with Wolff-Parkinson-White syndrome for laparoscopic cholecystectomy. Anesth Essays Res 7(2):270–272CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Seki S, Ichimiya T, Tsuchida H, Namiki A (1999) A case of normalization of Wolff-Parkinson-White syndrome conduction during propofol anesthesia. Anesthesiology 90(6):1779–1781CrossRefPubMed Seki S, Ichimiya T, Tsuchida H, Namiki A (1999) A case of normalization of Wolff-Parkinson-White syndrome conduction during propofol anesthesia. Anesthesiology 90(6):1779–1781CrossRefPubMed
5.
Zurück zum Zitat Stoetzer C, Reuter S, Doll T, Foadi N, Wegner F, Leffler A (2016) Inhibition of the cardiac Na+ channel α-subunit Nav1.5 by propofol and dexmedetomidine. Naunyn Schmiedebergs Arch Pharmacol 389(3):315–325CrossRefPubMed Stoetzer C, Reuter S, Doll T, Foadi N, Wegner F, Leffler A (2016) Inhibition of the cardiac Na+ channel α-subunit Nav1.5 by propofol and dexmedetomidine. Naunyn Schmiedebergs Arch Pharmacol 389(3):315–325CrossRefPubMed
6.
Zurück zum Zitat Liu Q, Kong AL, Chen R, Qian C, Liu SW, Sun BG, Wang LX, Song LS, Hong J (2011) Propofol and arrhythmias: two sides of the coin. Acta Pharmacol Sin 32(6):817–823CrossRefPubMedPubMedCentral Liu Q, Kong AL, Chen R, Qian C, Liu SW, Sun BG, Wang LX, Song LS, Hong J (2011) Propofol and arrhythmias: two sides of the coin. Acta Pharmacol Sin 32(6):817–823CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Chang RK, Wetzel GT, Shannon KM, Stevenson WG, Klitzner TS (1995 Nov) Age- and anesthesia-related changes in accessory pathway conduction in children with Wolff-Parkinson-White syndrome. Am J Cardiol 76(14):1074–1076CrossRefPubMed Chang RK, Wetzel GT, Shannon KM, Stevenson WG, Klitzner TS (1995 Nov) Age- and anesthesia-related changes in accessory pathway conduction in children with Wolff-Parkinson-White syndrome. Am J Cardiol 76(14):1074–1076CrossRefPubMed
Metadaten
Titel
Drug-Induced Loss of Preexcitation in Pediatric Patients with WPW Pattern During Electrophysiologic Study
verfasst von
C. Paech
F. Wagner
V. Strehlow
R. A. Gebauer
Publikationsdatum
10.09.2018
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 1/2019
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-018-1979-4

Weitere Artikel der Ausgabe 1/2019

Pediatric Cardiology 1/2019 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.